|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
MAY POTENTIALLY INCREASE THE RISK FOR ACETAMINOPHEN INDUCED HEPATOTOXICITY
|
CIMETIDINE IN COMBINATION INCREASES LEUCOPENIA & THROMBOCYTOPENIA
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
INHIBITS CYP3A4 AND CAN INCREASE SERUM AMIODARONE LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE IN COMBINATION WITH LAMIVUDINE & ZIDOVUDINE DELAYED THE EMERGENCE OF MUTATIONS CONFERRING RESISTANCE TO ZIDOVUDINE
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE HAS BEEN SEEN TO CAUSE EXAGERATED LEUKOPENIC & THROMBOCYTOPENIC EFFECT ON CONCURRENT USE
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CO-ADMINISTRATION LEADS TO AN INCREASE OF ABOUT 18% IN AUC OF LOSARTAN WITH NO EFFECT ON PHARMACOKINETICS OF ITS ACTIVE METABOLITES
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CO-ADMINISTRATION WITH ORAL CIMETIDINE MAY INCREASE PEAK METFORMIN PLASMA AND WHOLE BLOOD CONCENTRATIONS BY 60% AND 40%
|
METOCLOPRAMIDE MAY REDUCE THE BIOAVAILABILITY OF THE DRUG DUE TO REDUCTION OF GASTROINTESTINAL TRANSIT TIME
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
KETOCONAZOLE ABSORPTION IS REDUCED FROM THE GUT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CO-ADMINISTRATION HAS BEEN ASSOCIATED WITH CONFUSION, DISORIENTATION, RESPIRATORY DEPRESSION, APNEA & SEIZURE
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CO-ADMINISTRATION WITH CIMETIDINE MAY RESULT IN REDUCED CAFFEINE ELIMINATION ; LOWER DOSES OF CAFFEINE MAY BE NEEDED
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
H-2 RECEPTOR ANTAGONIST LIKE CIMETIDINE MAY DECREASE ITS ABSORPTION FROM THE GUT
|
H-2 RECEPTOR ANTAGONIST LIKE CIMETIDINE MAY DECREASE ITS ABSORPTION FROM THE GUT
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CISAPRIDE ENHANCES THE GASTRIC ABSORPTION OF CIMETIDINE & RANITIDINE WHILE THERE IS INCREASED PEAK PLASMA CONCENTRATION & AUC OF CISAPRIDE ASWELL BECAUSE OF CIMETIDINE AND RANITIDINE CO-ADMINISTRATION
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CO-ADMINISTRATION WITH ORAL CIMETIDINE MAY INCREASE PEAK METFORMIN PLASMA AND WHOLE BLOOD CONCENTRATIONS BY 60% AND 40%
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
VIT B12 ABSORPTION FROM THE GUT IS EFFECTED BY THE DRUG
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE IMPAIRS ITS METABOLISM & HENCE INCREASES ITS SERUM LEVELS
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE DECREASES RENAL CLEARANCE OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
KETOCONAZOLE ABSORPTION IS REDUCED FROM THE GUT
|
KETOCONAZOLE ABSORPTION IS REDUCED FROM THE GUT
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE DECREASES THE BIOAVAILABILITY OF THE DRUG, MAY BE DUE TO INCREASED GASTRIC PH LEADING TO REDUCED ABSORPTION
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|